Improving Development of Drug Treatments for Pregnant Women and the Fetus

The exclusion of pregnant populations, women of reproductive age, and the fetus from clinical trials of therapeutics is a major global public health issue. It is also a problem of inequity in medicines development, as pregnancy is a protected characteristic. The current regulatory requirements for d...

Descripción completa

Detalles Bibliográficos
Autores principales: David, Anna L., Ahmadzia, Homa, Ashcroft, Richard, Bucci-Rechtweg, Christina, Spencer, Rebecca N., Thornton, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315086/
https://www.ncbi.nlm.nih.gov/pubmed/35881237
http://dx.doi.org/10.1007/s43441-022-00433-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315086/
https://www.ncbi.nlm.nih.gov/pubmed/35881237
http://dx.doi.org/10.1007/s43441-022-00433-w

Ejemplares similares